AHCC14
Explore the RE-BALANCE study, which aims to prevent liver cancer by restoring bile acid balance through lifestyle changes, recruiting 90 patients from the AHCC10 ELEGANCE cohort.
Last updated on 22 June 2026
Trial summary of AHCC 14
AHCC14 | Restoring Bile Acid Homeostasis via Lifestyle Adjustments to prevent the Development of Liver Cancer (RE-BALANCE) (NCT07111130) |
|---|---|
Status | Planned recruitment of 90 patients from AHCC10 ELEGANCE cohort. |
Contributing Principal | Singapore Pierce Chow (National Cancer Centre), Guo Yuxin (Singapore General Hospital), Cindy Ng (Singapore General Hospital), Tan Ai Shan (Singapore General Hospital) |
Protocol Chair | Pierce Chow |